Zimbabwe has rejected a substantial US healthcare agreement valued at $367m (272 million pounds) over five years over Washington's request for sensitive data.
The decision came to light after a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government representative has since stated that the United States was demanding access to biological samples for research and commercial purposes but was unwilling to share the benefits from any future treatments.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for more dialogue to secure a deal acceptable to both sides so the country's vital HIV programme can continue.
Wider Background
This rejection follows a comparable situation in neighbouring Kenya, where a high court suspended a similar deal with the US following concerns were raised about the safety of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his administration was pursuing government-to-government deals to boost openness and accountability.
Based on statements, 16 nations in Africa have so far signed these new health pacts, representing over $18.3bn in new funding.
Specifics of the Declined Agreement
The funds for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," his statement read.
"In essence, our nation would provide the raw materials for scientific discovery with no certainty that the end products would be available to our people should a future disease outbreak arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending systems already established via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This system is designed to guarantee that when a nation provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to create them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome continued discussions with our US partners on how future collaboration might be arranged in a way that respects the sovereignty and interests of both nations."
Medical Community Response
Medical experts said it acknowledged the official position, but recommended that negotiations must proceed given that much of the nation's Aids initiatives were funded by international support.
"In cases where technical issues arise, including those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," the group added.
The situation underscores the continuing debate between accepting much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.